一项前性可行性研究,评估在重症儿童中实施基于模型的精确剂量
Izgi Bayraktar1, Merve Kaşıkcı2, Zuhal Benek1
1Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
Frontiers in pharmacology
|February 19, 2026
概括
模型知情精确剂量 (MIPD) 显示出优化重症儿童抗生素治疗的希望,尽管需要进一步的试验来确认其临床益处并完善其在儿科重症监护中的实施.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 药理动力学和药理动力学
- 临床药理学 临床药理学
背景情况:
- 在重症儿童中,由于生理变异性,最佳的抗生素暴露具有挑战性.
- 传统的剂量往往无法实现治疗目标的狭窄的治疗指数抗生素,如万科米辛和阿米卡辛.
研究的目的:
- 评估模型信息精确剂量 (MIPD) 在儿科重症监护病房的可行性和方法性能.
- 为了比较MIPD指导的剂量与标准护理 (SoC) 对于危急儿童的万科米辛和阿米卡辛.
主要方法:
- 具有前性,务实可行性研究与一个比较臂.
- 用MIPD或SoC治疗的儿童患者接受万科米或阿米卡的观察分析.
- 主要结局:预测准确度和模型合适度;次要结局:剂量优化,炎症标志物,安全性,治疗持续时间和死亡率.
主要成果:
- 模型匹配显示,与MIPD一起的万科米的适度改善,而在SoC组中保持不变.
- 两组的临床结果相似;然而,MIPD组的CRP和prokalcitonin减少数量较大,尽管不显著.
- 发炎标志物的基线不平衡混了临床结果的解释.
结论:
- MIPD是优化小儿重症监护中的抗生素暴露的潜在有价值的方法.
- 需要进一步的多中心试验来确认临床益处,并优化MIPD在这个人群中的实施.
相关概念视频
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
24
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
24
Drug Dosing: Infants and Children
344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344
Pharmacokinetics in Pediatric Patients: Drug Excretion
289
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
273
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
273
Pharmacokinetic Models: Comparison and Selection Criterion
392
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
392
Dosage Regimens: Designs and Approaches
350
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
350


